Free Trial

Skye Bioscience (SKYE) Earnings Date, Estimates & Call Transcripts

Skye Bioscience logo
$1.68 -0.04 (-2.05%)
As of 11:23 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Skye Bioscience Earnings Summary

Consensus EPS
(Mar. 20)
-$0.30
Actual EPS
(Mar. 20)
-$0.24 Beat By $0.06

Skye Bioscience released Q4 2024 earnings on March 20, 2025, reporting an EPS of -$0.24, which beat the consensus estimate of -$0.30 by $0.06. With a trailing EPS of -$0.72, Skye Bioscience's earnings are expected to decrease next year, from ($1.04) to ($1.18) per share.

Q4 2024 Earnings Resources

Get Skye Bioscience Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Skye Bioscience and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SKYE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Remove Ads

Skye Bioscience Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20261-$0.33-$0.33-$0.33
Remove Ads

Skye Bioscience Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/20/2025Q4 2024-$0.30-$0.24+$0.06-$0.24--
8/9/2024--$0.20-$0.20--$0.20--
5/10/2024Q1 2024-$0.16-$0.18 -$0.02-$0.18--
11/13/2023Q3 2023--$3.17 -$3.17-$3.17--
5/11/2023Q1 2023--$0.01 -$0.01-$0.01--

Skye Bioscience Earnings - Frequently Asked Questions

Skye Bioscience (NASDAQ:SKYE) last announced its quarterly earning data on Thursday, March 20, 2025. Learn more on SKYE's earnings history.

In the previous quarter, Skye Bioscience (NASDAQ:SKYE) reported ($0.24) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.30) by $0.06. Learn more on analysts' earnings estimate vs. SKYE's actual earnings.

The conference call for Skye Bioscience's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Skye Bioscience's latest earnings report can be read online.
Read Transcript

Skye Bioscience (NASDAQ:SKYE) has a recorded net income of -$37.65 million. SKYE has generated -$0.72 earnings per share over the last four quarters.

Skye Bioscience's earnings are expected to decrease from ($1.04) per share to ($1.18) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:SKYE) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners